Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
NCT00449748
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Systemic Mastocytosis
Interventions
DRUG:
RAD001 (Everolimus)
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]